Does cardiotrophin-1 eliminate hepatic steatosis in obese mice by mechanisms involving AMPK activation?
rCT-1 resolves hepatic steatosis in obese mice by mechanisms involving AMPK activation. rCT-1 deserves consideration as a potential therapy for NAFLD.
The results of our study have shown that MRI is an accurate method of evaluating patients with suspicion of colovesical fistulas, identifying the anatomy of the tract, as well as the etiology. This is not only useful for diagnosis, but also for surgical planning.